FALCONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 7.754
EU - Europa 2.059
AS - Asia 801
AF - Africa 106
OC - Oceania 11
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.749
Nazione #
US - Stati Uniti d'America 7.612
IT - Italia 724
BG - Bulgaria 515
SE - Svezia 427
CN - Cina 322
SG - Singapore 180
VN - Vietnam 164
CA - Canada 142
DE - Germania 127
GB - Regno Unito 122
HK - Hong Kong 70
CI - Costa d'Avorio 67
IN - India 34
AT - Austria 30
SN - Senegal 26
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 10
HU - Ungheria 10
RU - Federazione Russa 10
UA - Ucraina 10
CH - Svizzera 9
AU - Australia 8
FR - Francia 8
IS - Islanda 8
NG - Nigeria 8
PL - Polonia 8
BR - Brasile 7
ES - Italia 7
EU - Europa 7
FI - Finlandia 7
IE - Irlanda 5
JP - Giappone 5
EG - Egitto 4
SK - Slovacchia (Repubblica Slovacca) 4
BE - Belgio 3
GR - Grecia 3
NZ - Nuova Zelanda 3
TR - Turchia 3
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
IR - Iran 2
KR - Corea 2
PH - Filippine 2
RO - Romania 2
TW - Taiwan 2
BN - Brunei Darussalam 1
DZ - Algeria 1
ID - Indonesia 1
IL - Israele 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 10.749
Città #
Fairfield 1.209
Chandler 671
Woodbridge 556
Boulder 524
Ashburn 518
Sofia 515
Seattle 504
Houston 456
Wilmington 414
Cambridge 409
New York 325
Princeton 234
Lawrence 218
Milan 209
Des Moines 163
Ann Arbor 156
Medford 155
Beijing 137
Ottawa 131
San Diego 86
Florence 81
Hong Kong 70
Abidjan 67
London 66
Dong Ket 62
Pisa 54
Bremen 52
Serra 52
Frankfurt am Main 49
Nanjing 46
Rome 37
Vienna 28
Dakar 26
Hebei 25
Redwood City 24
Pune 22
Nanchang 20
Changsha 18
Dearborn 18
Falls Church 18
Stockholm 18
Tianjin 17
Vicopisano 17
Shenyang 16
Norwalk 15
Ogden 15
Brno 12
Jiaxing 12
Dubai 10
Budapest 9
Lancaster 9
Keflavik 8
Lagos 8
Toronto 8
Bern 7
Cedar Knolls 7
Chicago 7
Kunming 7
Livorno 7
Singapore 7
Warsaw 7
Kilburn 6
Los Angeles 6
Castelfranci 5
Catania 5
Leawood 5
Lucca 5
New Bedfont 5
Southwark 5
Washington 5
Bologna 4
Columbus 4
Dallas 4
Madrid 4
Trieste 4
Zhengzhou 4
Acton 3
Birmingham 3
Bratislava 3
Brussels 3
Chehalis 3
Chongqing 3
Collegeville 3
Dolo 3
Edinburgh 3
Hefei 3
Kolkata 3
Lappeenranta 3
L’Aquila 3
Messina 3
Moscow 3
Mountain View 3
Rapallo 3
Santa Maria Capua Vetere 3
Sydney 3
Tokyo 3
Urgnano 3
Atlanta 2
Banha 2
Belo Horizonte 2
Totale 8.788
Nome #
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 104
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 104
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 101
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 95
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 95
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy 95
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 95
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 93
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study 91
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 87
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019 86
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 85
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 85
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 83
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 83
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 83
Candidaemia after heart valve replacement surgery: recurrence as prosthetic valve endocarditis is an expected over one-year complication 82
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 82
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 82
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 82
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events 79
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 79
Healthcare-associated pneumonia: a never-ending story 78
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae 77
Clinical experience of anidulafungin for the treatment of patients with documented candidemia 76
High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis 74
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 74
Candidal thrombophlebitis of central veins: case report and review 72
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 72
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection 71
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 71
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 70
Is NOX2 Upregulation Implicated in Myocardial Injury in Patients with Pneumonia? 70
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature 70
Pneumonia in frail older patients: An up to date 69
CAP and HCAP are different? An unresolved question 69
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 68
Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study 68
Clinical features and outcome of patients with descending necrotizing mediastinitis: prospective analysis of 34 cases 68
Neglected tropical diseases in Europe: an emerging problem for health professionals 67
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia 67
Surveillance and management of multidrug-resistant microorganisms 67
Cirrhotic patients are at risk for health care-associated bacterial infections 66
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy 66
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort 64
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis 64
Physical, Mental and Sexual Health Among Transgender Women. A comparative Study Among Operated Transgender and Cisgender Women in a National Tertiary Referral Network 64
Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: An exploratory pilot study 64
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 63
Early identification of severe community-onset pneumonia in "frail elderly patient" 63
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae 63
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia 63
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 63
Health care associated pneumonia: a new clinical entity 63
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 63
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis 63
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 62
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey 62
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 61
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs 61
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 61
Role of aspirin in patients with septic shock: a complex and intriguing relationship 61
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia 61
Platelet activation is associated with myocardial infarction in patients with pneumonia 61
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 60
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 60
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 60
Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia 59
Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae 59
Performance status and in-hospital mortality of elderly patients with community acquired pneumonia 59
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 58
Healthcare-associated pneumonia and multidrug-resistant bacteria: Do we have a convincing answer? 58
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 58
Clonal Multidrug-Resistant Corynebacterium striatum Strains, Italy 58
Invasive aspergillosis in patients with liver disease 58
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 58
conservative medical therapy of infections following osteosynthesis: a retrospective analysis of a six-year experience 58
Role of multidrug-resistant pathogens in health-care-associated pneumonia 57
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 57
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 57
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 57
Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia 57
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections 57
Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia 57
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia 56
Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia 56
Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study 56
Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the Literature 56
A rare case of mycobacterial pseudoaneurysm of the superficial femoral artery 55
Conservative medical therapy of infections following osteosynthesis: A retrospective analysis of a six-year experience 55
Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation 55
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? 54
Identification and management of invasive mycoses in internal medicine: a road-map for physicians 54
Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli 54
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 54
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 54
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections 53
Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia 53
Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis 53
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 53
Totale 6.784
Categoria #
all - tutte 39.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019618 0 0 0 0 0 0 0 0 0 0 343 275
2019/20202.833 428 293 178 307 235 238 304 261 271 138 134 46
2020/20211.162 79 77 60 53 33 42 116 78 160 90 125 249
2021/20222.149 70 124 69 98 385 314 127 132 101 48 151 530
2022/20232.356 300 202 168 216 270 348 36 196 386 10 179 45
2023/20241.390 120 142 163 95 244 374 151 50 31 17 3 0
Totale 11.152